21239398

Source:http://linkedlifedata.com/resource/pubmed/id/21239398

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008109, umls-concept:C0086418, umls-concept:C0443286, umls-concept:C0574032, umls-concept:C0879427, umls-concept:C0995188, umls-concept:C1443775
pubmed:issue	2
pubmed:dateCreated	2011-1-31
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/cetuximab, http://linkedlifedata.com/resource/pubmed/chemical/panitumumab
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1569-8041
pubmed:author	pubmed-author:GreigWW, pubmed-author:KiffEE, pubmed-author:KopetzkyGG, pubmed-author:MayrbäurlBB, pubmed-author:NösslingerTT, pubmed-author:ReschGG, pubmed-author:Schaberl-MoserRR, pubmed-author:ScheithauerWW, pubmed-author:SliwaTT, pubmed-author:ThalerJJ
pubmed:issnType	Electronic
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	486-7
pubmed:meshHeading	pubmed-meshheading:21239398-Antibodies, Monoclonal, pubmed-meshheading:21239398-Antineoplastic Agents, pubmed-meshheading:21239398-Colorectal Neoplasms, pubmed-meshheading:21239398-Humans, pubmed-meshheading:21239398-Infusions, Intravenous, pubmed-meshheading:21239398-Neoplasm Metastasis, pubmed-meshheading:21239398-Receptor, Epidermal Growth Factor
pubmed:year	2011
pubmed:articleTitle	Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.
pubmed:publicationType	Letter